Annual Shareholders Equity
$60.02 M
+$5.22 M+9.52%
December 31, 2024
Summary
- As of March 10, 2025, ELEV annual stockholders equity is $60.02 million, with the most recent change of +$5.22 million (+9.52%) on December 31, 2024.
- During the last 3 years, ELEV annual shareholders equity has fallen by -$80.67 million (-57.34%).
- ELEV annual shareholders equity is now -57.34% below its all-time high of $140.70 million, reached on December 31, 2021.
Performance
ELEV Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$60.02 M
-$9.33 M-13.45%
December 31, 2024
Summary
- As of March 10, 2025, ELEV quarterly stockholders equity is $60.02 million, with the most recent change of -$9.33 million (-13.45%) on December 31, 2024.
- Over the past year, ELEV quarterly shareholders equity has stayed the same.
- ELEV quarterly shareholders equity is now -61.36% below its all-time high of $155.34 million, reached on June 30, 2021.
Performance
ELEV Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ELEV Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.5% | 0.0% |
| 3 y3 years | -57.3% | 0.0% |
| 5 y5 years | +1122.0% | 0.0% |
ELEV Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -57.3% | +22.4% | -57.3% | +77.8% |
| 5 y | 5-year | -57.3% | +360.1% | -61.4% | +313.6% |
| alltime | all time | -57.3% | +360.1% | -61.4% | +313.6% |
Elevation Oncology Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $60.02 M(+9.5%) | $60.02 M(-13.5%) |
| Sep 2024 | - | $69.36 M(-14.3%) |
| Jun 2024 | - | $80.92 M(+6.7%) |
| Mar 2024 | - | $75.82 M(+38.3%) |
| Dec 2023 | $54.81 M(+11.8%) | $54.81 M(-12.2%) |
| Sep 2023 | - | $62.42 M(-13.5%) |
| Jun 2023 | - | $72.18 M(+113.8%) |
| Mar 2023 | - | $33.76 M(-31.1%) |
| Dec 2022 | $49.03 M | $49.03 M(-26.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $67.12 M(-35.9%) |
| Jun 2022 | - | $104.68 M(-15.5%) |
| Mar 2022 | - | $123.87 M(-12.0%) |
| Dec 2021 | $140.70 M(-709.6%) | $140.70 M(-6.0%) |
| Sep 2021 | - | $149.63 M(-3.7%) |
| Jun 2021 | - | $155.34 M(-652.7%) |
| Mar 2021 | - | -$28.11 M(+21.8%) |
| Dec 2020 | -$23.08 M(+293.0%) | -$23.08 M |
| Dec 2019 | -$5.87 M | - |
FAQ
- What is Elevation Oncology annual stockholders equity?
- What is the all time high annual shareholders equity for Elevation Oncology?
- What is Elevation Oncology annual shareholders equity year-on-year change?
- What is Elevation Oncology quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Elevation Oncology?
- What is Elevation Oncology quarterly shareholders equity year-on-year change?
What is Elevation Oncology annual stockholders equity?
The current annual shareholders equity of ELEV is $60.02 M
What is the all time high annual shareholders equity for Elevation Oncology?
Elevation Oncology all-time high annual stockholders equity is $140.70 M
What is Elevation Oncology annual shareholders equity year-on-year change?
Over the past year, ELEV annual stockholders equity has changed by +$5.22 M (+9.52%)
What is Elevation Oncology quarterly stockholders equity?
The current quarterly shareholders equity of ELEV is $60.02 M
What is the all time high quarterly shareholders equity for Elevation Oncology?
Elevation Oncology all-time high quarterly stockholders equity is $155.34 M
What is Elevation Oncology quarterly shareholders equity year-on-year change?
Over the past year, ELEV quarterly stockholders equity has changed by $0.00 (0.00%)